Scientific publications

Acute tacrolimus nephrotoxicity in renal transplant patients treated with clarithromycin

Gómez G., Álvarez M.L., Errasti P. [SP], Lavilla F.J. [SP], García N. [SP], Ballester B., García I., Purroy A.
Renal Unit. University of Navarra. Pamplona (Spain)

Magazine: Transplantation Proceedings

Date: Sep 1, 1999

Nephrology [SP]

Tacrolimus (TCR) has been introduced recently in the treatment and prevention of rejection in a variety of organs. Its hepatic metabolism occurs via cytochrome P450 3A4. An increase or decrease in the whole blood levels may occur if we use substances that inhibit or induce cytochrome P450 3A4 activity.

Tacrolimus-induced nephrotoxic changes, clinical presentation, and probably its mechanism are the same as those of cyclosporine nephrotoxicity.

The mechanisms underlying acute nephrotoxicity are not fully understood, but it is hypothesized that TCR induces an increase in renal vasoconstriction with afferent arteriolar constriction and a decrease in glomerular filtration rate. Thus, TCR stimulates endothelin synthesis and release from renal cells, alters prostaglandin metabolism, and produces lipid peroxidation of the cell membrane. The decrease in renal function and extrarenal toxicity correlate better with high blood levels of TCR than with high dosage.

CITATION  Transplant Proc. 1999 Sep;31(6):2250-1

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra